Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meningitis UK was a prominent United Kingdom-based charity dedicated to the eradication of meningitis through the funding of preventative research and public health awareness campaigns. Founded by Steve Dayman following the loss of his son to the disease, the organization focused heavily on the development of a vaccine for Meningitis B. In 2013, Meningitis UK merged with the Meningitis Trust to form Meningitis Now, creating the largest meningitis charity in the UK. The organization played a critical role in clinical research funding and successfully campaigned for the introduction of life-saving vaccines into the UK's national immunization program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meningitis UK.